| 31st week of 2021 patent applcation highlights part 10 |
| Patent application number | Title | Published |
|---|
| 20210236510 | MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF | 2021-08-05 |
| 20210236511 | PHARMACEUTICAL FORMULATION OF ODEVIXIBAT | 2021-08-05 |
| 20210236512 | CLOZAPINE FOR THE TREATMENT OF A IMMUNOGLOBULIN DRIVEN B CELL DISEASE | 2021-08-05 |
| 20210236513 | NOVEL USES | 2021-08-05 |
| 20210236514 | TESTOSTERONE AND ESTRADIOL TRANSDERMAL SPRAY | 2021-08-05 |
| 20210236515 | FLUTICASONE FUROATE NASAL PREPARATION COMPOSITION | 2021-08-05 |
| 20210236516 | AUTOPHAGY ACTIVATORS FOR TREATING OR PREVENTING SKIN INJURY | 2021-08-05 |
| 20210236517 | TREATING VITAMIN D INSUFFICIENCY AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3 | 2021-08-05 |
| 20210236518 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION | 2021-08-05 |
| 20210236519 | CONTROLLED RELEASE DOSAGE FORMS OF 5-AMINOSALICYLIC ACID AND PROCESS THEREOF | 2021-08-05 |
| 20210236520 | METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN | 2021-08-05 |
| 20210236521 | Method For Improving Brain Function And A Dietary Supplement For Use In The Method | 2021-08-05 |
| 20210236522 | Method of Increasing Muscle Mass and Strength and Compositions Therefor | 2021-08-05 |
| 20210236523 | PSYCHEDELIC TREATMENT FOR HEADACHE DISORDERS | 2021-08-05 |
| 20210236524 | PHOSPHOLIPID COMPOUNDS AND FORMULATIONS | 2021-08-05 |
| 20210236525 | COMPOSITION FOR INHIBITING IMMUNE CELL PROLIFERATION COMPRISING SIALYLLACTOSE OR DERIVATIVE THEREOF AND METHOD THEREOF | 2021-08-05 |
| 20210236526 | IMMUNOMODULATORY OLIGOSACCHARIDES | 2021-08-05 |
| 20210236527 | IMMUNOMODULATORY OLIGOSACCHARIDES | 2021-08-05 |
| 20210236528 | COMPOSITION COMPRISING ISOMERS OF INOSITOL AND ITS USE | 2021-08-05 |
| 20210236529 | MULTI-TARGETED COMPOSITIONS FOR MITIGATING ACUTE RESPIRATORY DISTRESS SYNDROME | 2021-08-05 |
| 20210236530 | Methods and Compositions for Treating Mucositis | 2021-08-05 |
| 20210236531 | CYCLIC DINUCLEOTIDES AS AGONISTS OF STIMULATOR OF INTERFERON GENE DEPENDENT SIGNALLING | 2021-08-05 |
| 20210236532 | THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION AND METHOD FOR TREATING FRONTOTEMPORAL LOBAR DEGENERATION | 2021-08-05 |
| 20210236533 | METABOLICALLY STABILIZED DOUBLE STRANDED mRNA | 2021-08-05 |
| 20210236534 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EXPANDED REPEAT-ASSOCIATED DISORDERS | 2021-08-05 |
| 20210236535 | MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION | 2021-08-05 |
| 20210236536 | USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL | 2021-08-05 |
| 20210236537 | HIGH POROSITY CELLULOSIC STRUCTURES AND METHODS OF TREATMENT THEREWITH | 2021-08-05 |
| 20210236538 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | 2021-08-05 |
| 20210236539 | METHOD OF PROPHYLAXIS OF ZIKA VIRUS INFECTION | 2021-08-05 |
| 20210236540 | SYSTEMS AND METHODS FOR TREATING SKIN CONDITIONS WITH MAGNESIUM ION COMPOSITIONS | 2021-08-05 |
| 20210236541 | IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL | 2021-08-05 |
| 20210236542 | NOVEL GOLD-BASED NANOCRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR | 2021-08-05 |
| 20210236543 | Therapeutic Detoxification Compositions and Methods of Making and Using Same | 2021-08-05 |
| 20210236544 | METHODS OF MEDIATING MACROPHAGE PHENOTYPES | 2021-08-05 |
| 20210236545 | TUMOR IMMUNOTHERAPY COMPOSITION BASED ON ANTIGEN-PRESENTING CELLS ACTIVATED BY ATTENUATED LISTERIA MONOCYTOGENES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 2021-08-05 |
| 20210236546 | NKG2D DARIC RECEPTORS | 2021-08-05 |
| 20210236547 | RAPID PRODUCTION, EXPANSION, AND INCREASED PURITY OF CAR-T CELLS USING BEADS WITH PROTEIN L | 2021-08-05 |
| 20210236548 | TREATMENT OF PROSTATE CANCER USING CHIMERIC ANTIGEN RECEPTORS | 2021-08-05 |
| 20210236549 | IMPROVED T-CELL THERAPY METHOD | 2021-08-05 |
| 20210236550 | GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER | 2021-08-05 |
| 20210236551 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2021-08-05 |
| 20210236552 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2021-08-05 |
| 20210236553 | Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer | 2021-08-05 |
| 20210236554 | LOW DOSE RADIATION CONDITIONING FOR IMMUNOTHERAPY | 2021-08-05 |
| 20210236555 | Red Blood Cell Products and the Storage of Red Blood Cells in Containers Free of Phthalate Plasticizer | 2021-08-05 |
| 20210236556 | PREPARATION OF HUMAN PLATELET LYSATE (HPL) FROM REFRIGERATED WHOLE BLOOD PLATELETS | 2021-08-05 |
| 20210236557 | IMMATURE DENTAL PULP STEM CELLS AND METHODS OF USE TO TREAT BONE MARROW FAILURE | 2021-08-05 |
| 20210236558 | METHODS FOR INDUCING AN IMMUNE RESPONSE | 2021-08-05 |
| 20210236559 | GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF | 2021-08-05 |
| 20210236560 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | 2021-08-05 |
| 20210236561 | Compositions and Methods of Treatment for Chronic Rhinosinusitis | 2021-08-05 |
| 20210236562 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | 2021-08-05 |
| 20210236563 | MICROBIALS FOR FEED | 2021-08-05 |
| 20210236564 | COMPOSITION FOR USE IN THE TREATMENT AND/OR IMPROVEMENT OF SLEEP AND MOOD DISORDERS | 2021-08-05 |
| 20210236565 | PROBIOTICS FOR USE IN THE TREATMENT OF DIVERTICULOSIS AND DIVERTICULAR DISEASE | 2021-08-05 |
| 20210236566 | COMPOSITION BASED ON PROBIOTICS AND USES THEREOF | 2021-08-05 |
| 20210236567 | METHODS OF TREATING PSEUDOMONAS AERUGINOSA RESPIRATORY INFECTIONS | 2021-08-05 |
| 20210236568 | COMPOSITIONS AND METHODS FOR THERAPY WITH DENGUE VIRUS | 2021-08-05 |
| 20210236569 | BIOACTIVE FUNGAL COMPOUNDS PRODUCED BY SOLID-STATE FERMENTATION | 2021-08-05 |
| 20210236570 | Composition for anti-cancer, reducing anti-cancer side effects and suppressing cancer metastasis, including cannabis extract as active ingredient | 2021-08-05 |
| 20210236571 | COMPOSITION FOR RELIEVING PAIN AND PREVENTING OR ALLEVIATING STRESS-INVOLVED DISEASE, COMPRISING CANNABIS EXTRACT AS ACTIVE INGREDIENT | 2021-08-05 |
| 20210236572 | SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING | 2021-08-05 |
| 20210236573 | METHODS FOR PREPARATION OF CANNABIS OIL EXTRACTS AND COMPOSITIONS | 2021-08-05 |
| 20210236574 | PASSION FLOWER SEED EXTRACT, AND COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITIONS CONTAINING SAME | 2021-08-05 |
| 20210236575 | THERAPEUTIC COMBINATIONS OF CANNABINOIDS WITH CURCUMIN | 2021-08-05 |
| 20210236576 | COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING EXTRACTS OF ANEMONE RADDEANA, LONICERA SPECIES, AND ARALIA ELATA CONTAINING HIGH CONCENTRATION OF ANTITUMOR SAPONINS, AND METHOD FOR PREPARING SAME | 2021-08-05 |
| 20210236577 | LIVESTOCK FEED ADDITIVE | 2021-08-05 |
| 20210236578 | USE OF TOMATO EXTRACT AS ANTIHYPERTENSIVE AGENT AND PROCESS FOR MAKING WATER SOLUBLE SUGAR FREE TOMATO EXTRACT | 2021-08-05 |
| 20210236579 | THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTS | 2021-08-05 |
| 20210236580 | Methods and Compositions for Mitigating Symptoms of Acute Respiratory Distress Syndrome | 2021-08-05 |
| 20210236581 | Grape Products For Nonalcoholic Fatty Liver Disease And Other Uses | 2021-08-05 |
| 20210236582 | ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR PREPARING THEREOF AND USE OF THE SAME | 2021-08-05 |
| 20210236583 | Targeting the renin-angiotensin system for treatment of environment-and pathogen-induced lung injury | 2021-08-05 |
| 20210236584 | COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES | 2021-08-05 |
| 20210236585 | METHODS FOR REGULATING TRANSCRIPTION OF MULTIPLE GENES AND EXPRESSION OF MULTIPLE TARGETS | 2021-08-05 |
| 20210236586 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY | 2021-08-05 |
| 20210236587 | A RECONSTITUTABLE TEVERELIX-TFA COMPOSITION | 2021-08-05 |
| 20210236588 | TEVERELIX -TFA COMPOSITION | 2021-08-05 |
| 20210236589 | ANTIBIOTIC COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS | 2021-08-05 |
| 20210236590 | SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2 | 2021-08-05 |
| 20210236591 | OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE | 2021-08-05 |
| 20210236592 | FORMULATIONS OF VANCOMYCIN | 2021-08-05 |
| 20210236593 | METHODS OF SUPPORTING WEIGHT MAINTENANCE BY DECREASING THE ACTIVITY OF FAM46A | 2021-08-05 |
| 20210236594 | METHODS FOR IMPROVING FRAILTY AND AGING | 2021-08-05 |
| 20210236595 | METHOD OF MANAGING JOINT PAIN | 2021-08-05 |
| 20210236596 | METHODS FOR TREATING PEMPHIGUS DISORDERS | 2021-08-05 |
| 20210236597 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING POLYCYSTIC OVARY SYNDROME | 2021-08-05 |
| 20210236598 | METHODS FOR ORGAN REGENERATION | 2021-08-05 |
| 20210236599 | COMBINATION OF INTERLEUKIN-2 WITH AN INTERLEUKIN 1 INHIBITOR, CONJUGATES AND THERAPEUTIC USES THEREOF | 2021-08-05 |
| 20210236600 | STABLE LIQUID GONADOTROPIN FORMULATION | 2021-08-05 |
| 20210236601 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | 2021-08-05 |
| 20210236602 | Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug | 2021-08-05 |
| 20210236603 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2021-08-05 |
| 20210236604 | THERAPEUTIC TREATMENT FOR NEUROTROPHIC KERATOPATHY | 2021-08-05 |
| 20210236605 | COMBINATIONS OF OSTEOPONTIN AND 2'-FUCOSYLLACTOSE FOR USE AS MEDICAMENTS | 2021-08-05 |
| 20210236606 | GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL | 2021-08-05 |
| 20210236607 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS | 2021-08-05 |
| 20210236608 | PCSK9 VACCINE AND METHODS OF USING THE SAME | 2021-08-05 |
| 20210236609 | REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF | 2021-08-05 |
